MAPLIGHT THERAPEUTICS, INC.

Profile

Company Names

MAPLIGHT THERAPEUTICS, INC.
ALVARADO THERAPEUTICS, INC.

Addresses

800 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063

501 2ND STREET, SAN FRANCISCO, CA 94107

NASA AMES RESEARCH CENTER, BUILDING 261, ROOM 141, MOFFETT FIELD, CA 94035

Phone Numbers

(207) 653-8478
919-641-8778

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$356,187,906.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-07-18 
$188,187,915.00 
$372,449,989.00 
$184,262,074.00 
Equity 
5
2023-07-05 
$104,999,994.00 
$224,999,980.00 
$119,999,986.00 
Equity 
4
2022-10-25 
$11,999,999.00 
$11,999,999.00 
$0.00 
Equity 
3
2021-02-23 
$29,999,999.00 
$59,999,999.00 
$30,000,000.00 
Equity 
2
2019-08-23 
$15,999,999.00 
$15,999,999.00 
$0.00 
Equity 
1
2019-02-22 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER 
 
BISGAARD 
DIRECTOR
M2 GROUP HOLDINGS INC   |  LIGHT SCIENCES ONCOLOGY INC   |  OTONOMY, INC.   |  HIGH THROUGHPUT GENOMICS INC   |  HTG MOLECULAR DIAGNOSTICS INC   |  ALTHEOS, INC.   |  THESAN PHARMACEUTICALS, INC.   |  CETERIX ORTHOPAEDICS, INC.   |  HTG MOLECULAR DIAGNOSTICS, INC   |  RA PHARMACEUTICALS, INC.   |  OUTPOST MEDICINE, LLC   |  BOLT BIOTHERAPEUTICS, INC.   |  EARGO, INC.   |  ONCXERNA THERAPEUTICS, LTD.   |  MAPLIGHT THERAPEUTICS, INC.   |  ADDITION THERAPEUTICS, INC.
PETER 
A 
BISGAARD 
DIRECTOR
ALVARADO THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
ERIN 
 
FOFF 
EXECUTIVE OFFICER
MAPLIGHT THERAPEUTICS, INC.
TIMOTHY 
 
GARNETT 
DIRECTOR
OPHIREX, INC.   |  CARMOT THERAPEUTICS INC.   |  MAPLIGHT THERAPEUTICS, INC.
JONATHAN 
 
GILLIS 
EXECUTIVE OFFICER
ALVARADO THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
KRISTOPHER 
 
HANSON 
EXECUTIVE OFFICER
MAPLIGHT THERAPEUTICS, INC.
ANATOL 
 
KREITZER 
EXECUTIVE OFFICER
MAPLIGHT THERAPEUTICS, INC.
CHRISTOPHER 
A 
KROEGER 
EXECUTIVE OFFICER, DIRECTOR
CARDIOFOCUS, INC.   |  ALVARADO THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
JAMES 
 
LILLIE 
EXECUTIVE OFFICER
ALVARADO THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
JIM 
 
LILLIE 
EXECUTIVE OFFICER
ALVARADO THERAPEUTICS, INC.
NANNA 
 
LUNEBORG 
DIRECTOR
STARGAZER PHARMACEUTICALS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
CHARMAINE 
 
LYKINS 
EXECUTIVE OFFICER
MAPLIGHT THERAPEUTICS, INC.
ROBERT 
 
MALENKA 
DIRECTOR
ALVARADO THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
GEORGE 
 
PAVLOV 
DIRECTOR
ABOUND LOGIC INC.   |  OZMO INC   |  ASTUTE NETWORKS INC   |  IKANOS COMMUNICATIONS   |  CROSSING AUTOMATION INC   |  ALPHION CORP   |  QUINTIC HOLDINGS   |  PIXIM INC   |  CALYPTO DESIGN SYSTEMS INC   |  ALVARADO THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
VISHWAS 
 
SETIA 
EXECUTIVE OFFICER
MAPLIGHT THERAPEUTICS, INC.
JIM 
 
TRENKLE 
DIRECTOR
MAPLIGHT THERAPEUTICS, INC.   |  CONVERGENT THERAPEUTICS, INC.
MARIA 
 
WALKER 
DIRECTOR
FORGEROCK, INC.   |  PATIENT SQUARE EQUITY PARTNERS-A, LP   |  PATIENT SQUARE EQUITY PARTNERS, LP   |  PATIENT SQUARE EQUITY EXECUTIVES, LP   |  PATIENT SQUARE EQUITY EXECUTIVES QP, LP   |  PSC KR COINVEST, LP   |  MAPLIGHT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-07-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-07-18 
2023-11-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-05 
2023-07-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-05 
2022-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-25 
2021-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-23 
2019-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-23 
2019-03-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-22 
2019-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#